Abstracts Archive - Page 107 of 1683 - ATC Abstracts

2022 American Transplant Congress
Mortality and Cardiovascular Outcomes in Adult Non-Liver Solid Organ Transplant Patients with Non-Alcoholic Steatohepatitis
N. Dutta¹, N. Marka², J. Lake¹, N. Lim¹
¹Medicine, University of Minnesota, Minneapolis, MN, ²Clinical and Translational Sciences Institute, University of Minnesota, Minneapolis, MN
*Purpose: Despite the increasing incidence of non-alcoholic steatohepatitis (NASH) worldwide, its impact on mortality or major adverse cardiovascular events (MACE) in non-liver solid organ transplant…
2022 American Transplant Congress
A Third Dose of SARS-CoV-2 Vaccine Increases Neutralizing Antibodies Against Variants of Concern in Solid Organ Transplant Recipients
A. H. Karaba¹, X. Zhu¹, T. Ling¹, K. H. Wang¹, A. G. Rittenhouse¹, O. Akinde¹, Y. Eby¹, J. E. Ruff¹, J. N. Blankson¹, A. T. Abedon¹, J. L. Alejo¹, A. L. Cox¹, J. R. Bailey¹, E. A. Thompson¹, S. L. Klein¹, D. S. Warren¹, J. M. Garonzik-Wang², B. J. Boyarsky¹, I. Sitaras¹, A. Pekosz¹, D. L. Segev¹, A. A. Tobian¹, W. A. Werbel¹
¹Johns Hopkins University, Baltimore, MD, ²University of Wisconsin School of Medicine and Health, Madison, WI
*Purpose: Vaccine-induced SARS-CoV-2 antibody responses are attenuated in solid organ transplant recipients (SOTRs) and breakthrough infections are more common. Additional SARS-CoV-2 vaccine doses increase anti-spike…
2022 American Transplant Congress
COVID-19 Infection Post-Transplant: What is the Collateral Damage to the Graft? A Case for Pre-Transplant Vaccination
A. Fabick¹, E. Overly¹, V. Rao², V. Rohan³, N. Patel¹, D. DuBay³, C. Candland³, N. Pilch¹
¹Department of Pharmacy, Medical University of South Carolina, Charleston, SC, ²Department of Transplant Nephrology, Medical University of South Carolina, Charleston, SC, ³Department of Transplant Surgery, Medical University of South Carolina, Charleston, SC
*Purpose: COVID-19 produces an unpredictable immune reaction and is challenging to manage during active infection and post-infection, in kidney transplant (KTX) recipients. The first peak…
2022 American Transplant Congress
Liver and Kidney Transplantation from Donation After Circulatory Death Heart Donors in the US: Better Early Outcomes with Normothermic Regional Perfusion versus Cold Flush
M. Rosenzweig¹, R. Ruiz², E. Martinez¹, A. Gupta¹, H. Fernandez¹, S. Lee¹, N. Onaca¹, J. Bayer¹, G. J. McKenna¹, T. Ma¹, G. Testa³, A. Wall¹
¹Baylor University Medical Center, Dallas, TX, ²Baylor University Medical Center, Fort Worth, TX, ³Baylor Dallas, Dallas, TX
*Purpose: Donation after circulatory death (DCD) heart donation is increasingly common in the US. The two methods for DCD heart donation are normothermic regional perfusion…
2022 American Transplant Congress
Risk Factors for Early Post Transplant Cardiac Dysfunction After Liver Transplantation
V. Subramanian¹, K. Bowers², H. Kalagotla², J. Buggs¹, N. Kemmer¹, K. Dhanireddy¹
¹Transplant Institute, Tampa General Hospital, Tampa, FL, ²University of South Florida, Tampa, FL
*Purpose: Cardiovascular complications after liver transplantation (LTx) are a leading cause of morbidity and mortality. The goal of this study was to evaluate risk factors…
2022 American Transplant Congress
Impact of Graft Type, Presence and Type of Inflammatory Bowel Disease on Outcomes Following Liver Transplantation for Primary Sclerosing Cholangitis
S. Kumar¹, S. Lin², J. D. Schold³
¹Digestive Disease Institute, Cleveland Clinic Abu Dhabi, Abu Dhabi, United Arab Emirates, ²Department of Quantitative Health Sciences, Cleveland Clinic Foundation, Cleveland, OH, ³Center for Populations Health Research, Cleveland Clinic Foundation, Cleveland, OH
*Purpose: In Primary sclerosing cholangitis (PSC), concerns exist regarding outcomes following donation after circulatory death (DCD) liver transplantation (LT) due to risk of ischemic cholangiopathy…
2022 American Transplant Congress
Bioink Based on the DECM for 3D-Bioprinting of Bionic Pancreas – First Results of Animal
M. Klak¹, K. Kosowska¹, T. Bryniarski¹, I. Lojszczyk¹, T. Dobrzanski², G. Tymicki¹, A. Filip¹, A. A. Szczepankiewicz³, R. Olkowski⁴, A. Kosowska⁴, A. Berman¹, A. Kaminski⁴, M. Wszola¹
¹Foundation of Research and Science Development, Warsaw, Poland, ²Polbionica LTD, Warsaw, Poland, ³Institute of Experimental Biology M. Nencki PAN, Warsaw, Poland, ⁴Medical University of Warsaw, Warsaw, Poland
*Purpose: Tissue engineering is an interdisciplinary field involving activities based on two interrelated areas: developing new methods to repair, regenerate and replace damaged tissues and…
2022 American Transplant Congress
Towards Bionic Organs: Biocompatibility Of Newly Developed Porcine Decm-based Hydrogels.
M. Rachalewski, M. Klak, D. Ujazdowska, P. Cywoniuk, T. Dobrzanski, G. Tymicki, K. Kosowska, T. Bryniarski, A. Berman, M. Wszola
Foundation of Research and Science Development, Warsaw, Poland
*Purpose: There is a growing interest in fabrication of bioinks which on one hand biocompatible and on the other hand possess mechanical properties which would…
2022 American Transplant Congress
Patient and Provider Perspectives on Telehealth Clinic Visits Precipitated by the Covid-19 Viral Pandemic
L. Adamski¹, C. Alvarez¹, M. Patterson², C. Shen³, G. Kaur³, F. K. Butt³
¹Penn State College of Medicine, Hershey, PA, ²University of South Carolina, Greenville, SC, ³Penn State Milton S Hershey Medical Center, Hershey, PA
*Purpose: The transplant community had to adjust to a new way of practicing medicine during the COVID-19 viral pandemic. Our transplant center quickly adapted to…
2022 American Transplant Congress
Single Blind Randomized Controlled Trial Comparing BNT162b2 Vs JNJ-78436735 Vaccine As An Additional Dose After Two Doses Of BNT162b2 Vaccine In Solid Organ Transplant (SOT) Recipients
Y. Natori¹, E. Martin², A. Mattiazzi³, J. Bini Viotti¹, K. S. Ortecho⁴, S. Pallikkuth⁵, S. Anjan¹, J. Simkins¹, G. Guerra³
¹Department of Medicine, Division of Infectious Diseases, University of Miami, Miami, FL, ²Department of Medicine, Division of Hepatology, University of Miami, Miami, FL, ³Department of Medicine, Division of Nephrology, University of Miami, Miami, FL, ⁴Miami Transplant Institute, Jackson Health System, Miami, FL, ⁵University of Miami, Miami, FL
*Purpose: Even though a high efficacy and immunogenicity of COVID-19 vaccines have been reported in the general population, vaccine immunogenicity is suboptimal in SOT recipients…